Evidence map›Paper›PMID 18759927›Full record

ReviewImmunological reviews2008

Regulation of B-cell entry into the cell cycle.

Sabrina Richards, Chie Watanabe, Lorna Santos, Andrew Craxton, Edward A Clark

Open access · greenAbstract readReview
In one paragraph

Review in Immunological reviews, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 64 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Single-nuclei transcriptome analysis of IgMFrontiers in immunology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. IL-33 Is a Cell-Intrinsic Regulator of Fitness during Early B Cell Development.Journal of immunology (Baltimore, Md. : 1950) · 2019
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Regulation of primary response genes in B cells.The Journal of biological chemistry · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Sabrina RichardsDepartment of Immunology and Microbiology, University of Washington, Seattle, WA 98195, USA.
Chie Watanabe
Lorna Santos
Andrew Craxton
Edward A Clark
University of Washington · USUniversity of Leicester · GB

Funding

Programming protective immunity by targeting antigens to the CD180 receptorR01AI052203 · NIAID · UNIVERSITY OF WASHINGTON · PI FULLER, DEBORAH H. · 2003 to 2019
$6.3M
STRUCTURE/FUNCTION HUMAN B CELL DIFFERENTIATION ANTIGENSR01GM037905 · NIGMS · UNIVERSITY OF WASHINGTON · PI CLARK, EDWARD A · 1987 to 2007
$2.4M
Dendritic cells, Mucosal Immunity and C-type LectinsR01DE016381 · NIDCR · UNIVERSITY OF WASHINGTON · PI CLARK, EDWARD A · 2005 to 2009
$1.8M
CD22 AND B CELL RECEPTOR INDUCED DEATHR01AI044250 · NIAID · UNIVERSITY OF WASHINGTON · PI CLARK, EDWARD A · 1999 to 2003
$1.1M
NIAID NIH HHS AI44250NIAID NIH HHS AI52203NIAID NIH HHS R01 AI044250NIAID NIH HHS R01 AI052203NIDCR NIH HHS DE16381NIDCR NIH HHS R01 DE016381NIGMS NIH HHS GM37905NIGMS NIH HHS R01 GM037905
6 · The paper itself

Abstract

B cells are induced to enter the cell cycle by stimuli including ligation of the B-cell receptor (BCR) complex and Toll-like receptor (TLR) agonists. This review discusses the contribution of several molecules, which act at distinct steps in B-cell activation. The adapter molecule Bam32 (B-lymphocyte adapter of 32 kDa) helps promote BCR-induced cell cycle entry, while the secondary messenger superoxide has the opposite effect. Bam32 and superoxide may fine tune BCR-induced activation by competing for the same limited resources, namely Rac1 and the plasma membrane phospholipid PI(3,4)P(2). The co-receptor CD22 can inhibit BCR-induced proliferation by binding to novel CD22 ligands. Finally, regulators of B-cell survival and death also play roles in B-cell transit through the cell cycle. Caspase 6 negatively regulates CD40- and TLR-dependent G(1) entry, while acting later in the cell cycle to promote S-phase entry. Caspase 6 deficiency predisposes B cells to differentiate rather than proliferate after stimulation. Bim, a pro-apoptotic Bcl-2 family member, exerts a positive regulatory effect on cell cycle entry, which is opposed by Bcl-2. New insights into what regulates B-cell transit through the cell cycle may lead to thoughtful design of highly selective drugs that target pathogenic B cells.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsApoptosis Regulatory ProteinsB-LymphocytesCell CycleCell ProliferationCell SurvivalHumansLymphocyte ActivationNADPH OxidasesReceptors, Antigen, B-CellSialic Acid Binding Ig-like Lectin 2Signal TransductionAdaptor Proteins, Signal TransducingApoptosis Regulatory ProteinsDAPP1 protein, humanNADPH OxidasesReceptors, Antigen, B-CellSialic Acid Binding Ig-like Lectin 2

Identifiers

PMID18759927
PMCPMC2728081
OpenAlexW2122916488

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.